血清sCD163水平与糖尿病性骨质疏松的关系  

Relationship of bone density with sCD163 in diabetic osteoporosis

作　　者：陈爱宝[1] 曾国庆[1] 龚琦[2] 杨学洪 穆继宏 

机构地区：[1]解放军第425医院创伤骨科,海南三亚572008 [2]解放军第425医院医务处,海南三亚572008

出　　处：《中国医药导报》2017年第27期101-104,共4页China Medical Herald

基　　金：海南省三亚市医疗卫生科技创新项目(2014YW46)

摘　　要：目的探讨糖尿病(DM)患者骨密度(BMD)变化与血清可溶性血红蛋白清道夫受体(sCD163)的关系。方法选择2015年1月~2016年4月在解放军第425医院就诊的2型糖尿病患者82例为糖尿病组,再分为骨质疏松组(45例)和非骨质疏松组(37例),同时选取健康人30例作为对照组。双能X线骨密度仪测定受试者腰椎L_1~L_4的BMD,全自动生化分析仪测定受试者空腹血糖(FPG)、糖化血红蛋白(HbA_(1c)),ELISA法测定受试者血清sCD163水平。结果糖尿病组FGP、HbA1c、sCD163均高于对照组,差异有统计学意义(P<0.05);糖尿病组的BMD低于对照组,差异有统计学意义(P<0.05)。糖尿病骨质疏松组的sCD163水平高于非骨质疏松组,而骨质疏松组的BMD水平低于非骨质疏松组,差异有统计学意义(P<0.05)。Pearson相关性分析显示:sCD163水平与BMD呈负相关(r=-0.880,P<0.05)。Logistic回归分析结果表明sCD163是糖尿病性骨质疏松的风险因素(OR=1.490,P<0.05)。结论血清sCD163的变化与糖尿病骨质疏松的发生密切相关。Objective To investigate the correlation of the bone mineral density （BMD） in patients with type 2 diabetes mellitus with sCD163. Methods From January 2015 to April 2016, in 425th Hospital of PLA, 82 patients with type 2 diabetes mellitus were selected as DM group, DM group was divided into osteoporotic DM group （45 cases） and non-osteoporotic DM group （37 cases）, at the same time, 30 healthy persons were enrolled as the control group. BMD of lumbar span （L1-L4） was measured with dual energy X-ray absorptiometry, the levels of FPB and HbA1c were analysed by automatic biochemistry analyzer. The serum level of sCD163 was detected by ELISA. Results The levels of FGP, HbA1c, sCD163 in DM group were significantly higher than those in control group （P 〈 0.05）. The BMD in DM group was significantly lower than that in control group （P 〈 0.05）. The level of sCD163 in osteoporotic DM group was significantly higher than that in non-osteoporotic DM group （P 〈 0.05）, and the level of BMD more declined in osteoporotic DM group than that in non-osteoporotic DM group （P 〈 0.05）. Furthermore, the result of Pearson correlation analysis indicated that BMD was negatively correlated with sCD163 （r = -0.880, P 〈 0.05）. Logistic regression analysis indicated that in DM patients sCD163 was the risk factor for osteoporosis （OR = 1.490, P 〈 0.05）. Conclusion The increased level of sCD163 is related to the osteoporosis in DM.

关 键 词：糖尿病 骨质疏松 骨密度 可溶性血红蛋白清道夫受体 

分 类 号：R681[医药卫生—骨科学]